Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?

Yoshihisa Tokumaru, Lan Le, Mariko Asaoka, Manabu Futamura, Takashi Ishikawa, Kazuhiro Yoshida, Kazuaki Takabe